Job Listings


Here are our current job openings. Please click on the job title for more information, and apply from that page if you are interested.

Use this form to perform another job search

The system cannot access your location for 1 of 2 reasons:
  1. Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
  2. Your location information has yet to be received. Please wait a moment then hit [Search] again.


Jounce Therapeutics, Inc. is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of our Translational Science Platform, we first focus on specific cell types within tumors to prioritize targets, and then identify related biomarkers designed to match the right therapy to the right patient. Jounce was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures. In July 2016, Jounce announced a global strategic collaboration with Celgene Corporation. This global strategic collaboration, which included a $225.0 million upfront payment and a $36.1 million equity investment, is primarily focused on co developing and co commercializing innovative biologic immunotherapy treatments for patients with cancer.

Jounce is an equal employment opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law.

All applicants should be legally entitled to work for any employer in the U.S.

Note to Employment Agencies: Please do not forward any agency resumes. The company will not be responsible for any fees related to resumes that are unsolicited.
Click column header to sort

Search Results

Job ID
2017-1115
US-MA-Cambridge

The Medical Director will design and execute clinical development strategy for Jounce’s lead immune-oncology product candidate, JTX-2011, an agonist antibody to ICOS.  He or she will be responsible for all clinical activities related to JTX-2011 sponsored studies.  As Jounce grows and brings new drugs into the clinic, there will be an opportunity to take on more responsibility and play an important leadership role in the company.

Job ID
2017-1113
US-MA-Cambridge

The Cell Line Development group at Jounce Therapeutics is looking for a Senior Research Associate experienced in mammalian cell culture. The successful candidate will play an important role in the generation of stable cell lines for the production of novel biotherapeutics for immuno-oncology.  S/he will be responsible for screening, cloning and characterizing CHO cell lines using cell biology, molecular biology and biochemistry techniques.  As a member of the CMC group, s/he will have the opportunity to work cross-functionally as part of internal multi-disciplinary program teams, and will support experimental design and planning, conducting experiments, and communicating results. This is an exciting position in the dynamic field of immuno-oncology which provides opportunity for growth in a fast-paced, start-up environment.

Job ID
2017-1112
US-MA-Cambridge

Jounce Therapeutics is a dynamic, growing biotech company, located in Cambridge, MA.  We are seeking a Research Administrator who will provide a high level of support to the Sr. VP of Research and the broader research team.  In this role you will have the opportunity to work side by side with a world class team of scientific leaders focused on developing new treatments for cancer. 

This key position reports to the Sr. VP of Research and will be a proactive member of the broader administrative team.

If you are passionate about science, and have strong administrative and communication skills, this is the job for you!

Job ID
2017-1110
US-MA-Cambridge

The IT and Informatics group at Jounce Therapeutics is looking for a seasoned Senior Infrastructure and Security Engineer to join the Jounce IT team. This role will be responsible for the day to day management of the Jounce IT infrastructure and security systems. They will be responsible for the identification, investigation, interpreting and remediating security vulnerabilities / breaches detected by the security and infrastructure management systems. Working closely with the Information Technology Manager on variety infrastructure and security driven initiatives. This is an exciting position in the dynamic field of immuno-oncology which provides opportunity for growth in a fast-paced, start-up environment.

 

Job ID
2017-1109
US-MA-Cambridge

Jounce Therapeutics, Inc. (JNCE) is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial.

 

The Business Development Director will drive Jounce’s business development activities, support the BD strategy, and alliance management functions.  In this newly created position you will play a key role in leading a range of business development transactional activities at Jounce.  This highly visible position reports to the Chief Business Officer.  If you thrive in a fast-paced, high science culture, this is an outstanding opportunity for you

Job ID
2017-1107
US-MA-Cambridge

Jounce Therapeutics, Inc. (JNCE) is a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long‑lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. Jounce’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates ICOS and is currently in a Phase 1/2 trial. 

Job ID
2017-1060
US-MA-Cambridge